Jane Street’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.16M | Buy |
2,665,938
+941,634
| +55% | +$1.37M | ﹤0.01% | 3778 |
|
|
2025
Q4 | $1.98M | Buy |
1,724,304
+1,267,774
| +278% | +$1.74M | ﹤0.01% | 4827 |
|
|
2025
Q3 | $616K | Sell |
456,530
-348,137
| -43% | -$395K | ﹤0.01% | 7399 |
|
|
2025
Q2 | $761K | Buy |
+804,667
| New | +$521K | ﹤0.01% | 6119 |
|
|
2025
Q1 | – | Sell |
-220,264
| Closed | -$163K | – | 10123 |
|
|
2024
Q4 | $163K | Buy |
220,264
+134,903
| +158% | +$163K | ﹤0.01% | 8537 |
|
|
2024
Q3 | $134K | Sell |
85,361
-44,495
| -34% | -$79.2K | ﹤0.01% | 8863 |
|
|
2024
Q2 | $218K | Sell |
129,856
-151,732
| -54% | -$272K | ﹤0.01% | 8261 |
|
|
2024
Q1 | $676K | Buy |
281,588
+9,221
| +3% | +$19.8K | ﹤0.01% | 6135 |
|
|
2023
Q4 | $417K | Buy |
272,367
+190,437
| +232% | +$226K | ﹤0.01% | 7080 |
|
|
2023
Q3 | $89.3K | Buy |
81,930
+61,382
| +299% | +$108K | ﹤0.01% | 7999 |
|
|
2023
Q2 | $47.1K | Sell |
20,548
-22,975
| -53% | -$61K | ﹤0.01% | 8223 |
|
|
2023
Q1 | $106K | Buy |
43,523
+26,192
| +151% | +$60K | ﹤0.01% | 8199 |
|
|
2022
Q4 | $33.1K | Sell |
17,331
-17,210
| -50% | -$36.6K | ﹤0.01% | 8476 |
|
|
2022
Q3 | $83K | Buy |
+34,541
| New | +$95.6K | ﹤0.01% | 8739 |
|
|
2022
Q2 | – | Sell |
-19,723
| Closed | -$41K | – | 10384 |
|
|
2022
Q1 | $41K | Sell |
19,723
-18,744
| -49% | -$52K | ﹤0.01% | 9752 |
|
|
2021
Q4 | $152K | Sell |
38,467
-1,253
| -3% | -$6.09K | ﹤0.01% | 8997 |
|
|
2021
Q3 | $191K | Buy |
39,720
+24,509
| +161% | +$101K | ﹤0.01% | 8885 |
|
|
2021
Q2 | $70K | Sell |
15,211
-7,465
| -33% | -$36K | ﹤0.01% | 9405 |
|
|
2021
Q1 | $133K | Buy |
+22,676
| New | +$157K | ﹤0.01% | 8517 |
|
|
2020
Q4 | – | Sell |
-12,011
| Closed | -$17K | – | 7843 |
|
|
2020
Q3 | $17K | Sell |
12,011
-6,136
| -34% | -$10.9K | ﹤0.01% | 7038 |
|
|
2020
Q2 | $36K | Buy |
+18,147
| New | +$35.6K | ﹤0.01% | 6909 |
|
|
2020
Q1 | – | Sell |
-13,991
| Closed | -$58K | – | 5708 |
|
|
2019
Q4 | $58K | Sell |
13,991
-47,175
| -77% | -$182K | ﹤0.01% | 4896 |
|
|
2019
Q3 | $184K | Buy |
+61,166
| New | +$189K | ﹤0.01% | 4672 |
|
|
2014
Q1 | – | Sell |
-6,409
| Closed | -$81K | – | 2906 |
|
|
2013
Q4 | $81K | Buy |
6,409
+2,810
| +78% | +$44.7K | ﹤0.01% | 2208 |
|
|
2013
Q3 | $60K | Buy |
+3,599
| New | +$60.4K | ﹤0.01% | 2591 |
|
Other funds holding LXRX
AG
SL
SC
VCM
Jane Street's LXRX Position: Q1 2026 in Review
Jane Street increased its Lexicon Pharmaceuticals (LXRX) stake by 55% in Q1 2026, buying an estimated $1.37M and bringing the position to 2,665,938 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.
Jane Street first reported a position in LXRX in Q3 2013 and has held it in 25 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.
- Jane Street held 2,665,938 shares of Lexicon Pharmaceuticals worth $4.16M as of Q1 2026.
- Jane Street bought 941,634 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $1.37M.
- Lexicon Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3778 holding.
- Jane Street first reported a position in Lexicon Pharmaceuticals in Q3 2013 and has held it in 25 quarters since.
- 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.